Table 2.
The distribution of abdominal fat measured by CT scan among BE cases and the two control groups
| BE cases (n=173) | Colonoscopy controls (n=343) | Unadjusted OR | Adjusted* OR | Endoscopy controls (n=172) | Unadjusted OR | Adjusted* OR | |
|---|---|---|---|---|---|---|---|
| VAT | |||||||
| Median | 206.9 | 163.7 | 172.8 | ||||
| 1st tertile (<142.92) | 41 (23) | 128 (37) | 1.00 | 1.00 | 60 (35) | 1.00 | 1.00 |
| 2nd tertile (142.923–<226.03) | 65 (38) | 114 (33) | 1.78 (1.12 to 2.84) | 1.40 (0.85 to 2.30) | 51 (30) | 1.87 (1.09 to 3.20) | 1.58 (0.89 to 2.79) |
| 3rd tertile (≥226.03) | 67 (39) | 101 (30) | 2.07 (1.30 to 3.31) | 1.30 (0.79 to 2.15) | 61 (35) | 1.61 (0.95 to 2.72) | 1.05 (0.59 to 1.85) |
| p Trend | 0.002 | 0.11 | |||||
| SAT | |||||||
| Median | 288.1 | 311.7 | 286.4 | ||||
| 1st tertile (<246.91) | 55 (32) | 112 (33) | 1.00 | 1.00 | 62 (36) | 1.00 | 1.00 |
| 2nd tertile (246.91–<360.18) | 73 (42) | 106 (31) | 1.40 (0.90 to 2.18) | 1.72 (1.01 to 2.92) | 51 (30) | 1.61 (0.97 to 2.69) | 1.54 (0.97 to 2.46) |
| 3rd tertile (≥360.18) | 45 (26) | 125 (36) | 0.73 (0.46 to 1.17) | 1.04 (0.59 to 1.84) | 59 (34) | 0.86 (0.51 to 1.46) | 0.80 (0.48 to 1.30) |
| p Trend | 0.19 | 0.67 | |||||
| VAT to SAT ratio | |||||||
| Median | 0.65 | 0.55 | 0.61 | ||||
| 1st tertile (<0.47) | 39 (22) | 134 (39) | 1.00 | 1.00 | 56 (33) | 1.00 | 1.00 |
| 2nd tertile (0.47–<0.76) | 65 (38) | 111 (32) | 2.01 (1.26 to 3.22) | 1.63 (0.98 to 2.68) | 54 (31) | 1.73 (1.00 to 2.98) | 1.00 (0.53 to 1.92) |
| 3rd tertile (≥0.76) | 69 (40) | 98 (29) | 2.42 (1.51 to 3.88) | 1.47 (0.88 to 2.45) | 62 (36) | 1.60 (0.94 to 2.73) | 0.84 (0.44 to 1.60) |
| p Trend | <0.001 | 0.12 | |||||
*
Adjusted for age, gender, race, NSAID, Helicobacter pylori infection, smoking and alcohol.
BE, Barrett’s oesophagus; NSAID, non-steroidal anti-inflammatory drug; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue.